Skip to main content
Premium Trial:

Request an Annual Quote

Kinaxo Lands $1.4M From German Gov't to Develop Small-Molecule Quantification Tool

NEW YORK (GenomeWeb News) — Kinaxo Biotechnologies has received around €1 million (approximately $1.4 million) from the German Ministry for Education and Research to develop a “universally applicable” chemical proteomics tool, the company said Monday.
The company said it plans to use the platform to “quantify small molecule-protein interactions in mammalian tissues and cell lines.”
Kinaxo’s head of research, Klaus Godl, said the company will use the funds to combine mass spectrometry with its KinaTor technology, in order to distinguish relevant drug-protein interactions from weak binding as well as determine a “compound’s affinity without the need of in vitro assays.”
These technologies are to be developed with help from Lothar Jänsch of the Helmholtz Institute and Henrik Daub of the Max Planck Institute.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.